ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00692900
Recruitment Status : Completed
First Posted : June 6, 2008
Last Update Posted : February 2, 2016
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Robert Edwards, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : October 2013